Core Insights - The report highlights the strong performance of Times Angel, with a 33% year-on-year revenue growth to $160 million in the first half of 2025, driven primarily by rapid expansion in overseas markets [2] - The report maintains a "Buy" rating for Times Angel, adjusting the target price to HKD 86.47 based on a sum-of-the-parts valuation, reflecting a 15x P/E for its mature domestic business and an 8x P/S for its rapidly expanding overseas operations [7] - The report indicates that while domestic case volume remains resilient, pricing pressures are expected to continue, impacting profit margins [6] Company Analysis Times Angel - Times Angel's overseas invisible orthodontics case volume reached 117,200, a 103% increase year-on-year, with overseas revenue growing 123% to $71.62 million [7] - The domestic business saw case volume grow 14% year-on-year to 108,600, but revenue remained flat at $89.68 million due to declining average selling prices [6] - The report anticipates that despite short-term profit margin pressures, the company's strategic investments in compliance and localization will support sustainable global expansion [7] Beike (贝壳) - Beike reported a 11% year-on-year revenue growth to RMB 26 billion in Q2 2025, driven by new home transactions and rental services [8] - The non-GAAP net profit for the quarter was RMB 1.8 billion, a 32% decline year-on-year, reflecting ongoing industry headwinds [8] - The report suggests that Beike is on the right track to improve operational efficiency, which may enhance profitability during industry recovery [8] Luxshare Precision (立讯精密) - Luxshare's revenue and net profit both grew 23% year-on-year in the first half of 2025, with strong growth in communication and automotive sectors [9] - The gross margin improved to 12.0% in Q2 2025, driven by product mix enhancement and operational efficiency [9] - The report highlights potential growth drivers including increased iPhone market share and expansion in the automotive sector [9] BOE Technology (京东方) - BOE's revenue grew 8% year-on-year in the first half of 2025, with net profit increasing by 5% [10] - The automotive display segment outperformed the industry, with high-end products seeing significant growth [10] - The report projects that BOE will continue to grow faster than the industry average in the second half of 2025 [10] EHang (亿航智能) - EHang delivered 68 eVTOL aircraft in Q2 2025, a 39% year-on-year increase, despite lowering its full-year revenue guidance by over 40% [11] - The management emphasizes that the reduction in delivery targets is due to safety considerations rather than a decrease in end-demand [11] - The report maintains a positive outlook on EHang's growth potential in the eVTOL market [11] Green Tea Group (绿茶集团) - Green Tea Group reported positive same-store sales growth despite a decline in average price per item [10] - The report anticipates continued sales growth and margin improvement driven by strong takeaway orders and new product launches [10] - The target price is adjusted to HKD 10.74, reflecting confidence in the company's growth trajectory [11]

Core Viewpoint - Align Technology, the parent company of Invisalign, has initiated a series of patent infringement lawsuits against Angelalign in the US, Europe, and China, claiming infringement on core technologies related to multi-layer aligner materials, treatment planning, and aligner characteristics [1][3][15] Group 1: Legal Actions and Responses - Align Technology has filed lawsuits claiming Angelalign infringed on five US utility patents, including two material patents and three technology patents, which are crucial to Align's global intellectual property portfolio [3][15] - Angelalign has publicly denied the infringement allegations, stating they are "baseless" and has committed to actively defending against the lawsuits [1][2][5] - The legal actions reflect Align Technology's strategy to protect its intellectual property and reshape the competitive landscape to align with its research-driven development model [2][15] Group 2: Market Dynamics and Competitive Landscape - Angelalign has gained significant market share in China, reaching 41.9% in 2023, surpassing Align Technology by 10 percentage points [9][12] - Angelalign's revenue and net profit are projected to grow significantly, with a year-on-year increase of approximately 538.1% to 604.8% expected in the first half of 2025 [9][12] - Align Technology's performance in China has been declining, with revenue growth dropping from 90% in 2018 to less than 2% in 2020, indicating challenges in maintaining market presence [12][15] Group 3: Strategic Initiatives - Angelalign's strategy includes a tiered branding approach and partnerships to penetrate lower-tier cities, offering lower-priced products to attract price-sensitive consumers [13][15] - The company has expanded its international presence, with 39.1% of its cases now coming from outside China, and has established subsidiaries in key markets like the US and Europe [14][15] - Align Technology's reliance on high-margin structures is threatened by Angelalign's cost-effective and localized production strategies, which could disrupt traditional competitive advantages in the industry [15][16]

Macro Strategy - The report suggests that the overlap of population peak and consumption peak from 2025 to 2035 may lead to more optimistic growth in total consumption compared to 2020-2025, as the proportion of the population aged 40-49 is expected to increase from 13.8% to 15.9% [1] Fixed Income - The report indicates that the bond market is experiencing a slight upward trend in yields due to the recent reserve requirement ratio cut, with expectations for the DR007 to stabilize around 1.4%-1.5% [3][4] - The issuance of secondary capital bonds totaled 400 billion yuan, with a trading volume of approximately 242.4 billion yuan, reflecting an increase of 53.8 billion yuan from the previous week [4] - Green bond issuance reached 10 bonds with a total scale of approximately 10.3 billion yuan, an increase of 2.5 billion yuan from the previous week [5] Real Estate - New housing transaction area increased month-on-month, while second-hand housing transactions also saw a rise, indicating a potential recovery in the real estate market [6] - The report recommends several companies in real estate development, property management, and real estate brokerage, including China Resources Land, Poly Developments, and Beike [6] Engineering Machinery - The report highlights a year-on-year increase of 18% in excavator sales for April, indicating a positive outlook for the engineering machinery industry [7] Gas Industry - The report anticipates a relaxed supply situation for gas companies, with a focus on cost optimization and price mechanism adjustments, recommending companies like Xin'ao Energy and China Gas [9] Petrochemical Industry - The report notes a significant increase in polyester prices, with POY, FDY, and DTY prices rising by 5.5%, 5.9%, and 3.9% respectively, indicating strong demand in the petrochemical sector [10] Retail Industry - The report emphasizes the strong performance of domestic brands during the 618 shopping festival, recommending companies like Ruya Chen and Juzhi Biological [11] Construction Materials - The report indicates a stable economic outlook with improved supply dynamics in the construction materials sector, recommending companies like China Communications Construction and China Railway Construction [12][18] Automotive Industry - The report maintains a positive outlook for the automotive sector, highlighting a 6.5% month-on-month increase in passenger car sales, with a focus on AI and robotics as key growth drivers [19] Pharmaceutical Industry - The report identifies a fast track for the development of three-antibody drugs, recommending companies like Zai Lab and 3SBio for investment [21][22] Electronic Industry - The report discusses the growing demand for AI infrastructure, particularly in the Middle East, and suggests focusing on domestic hardware suppliers for AI applications [23] Non-Banking Financial Industry - The report highlights the low average valuation in the non-banking financial sector, recommending companies like New China Life Insurance and CITIC Securities for investment [25]

Macro Commentary - The US economy shows signs of slowing down, with significant declines in retail and manufacturing output due to tariff impacts, particularly affecting durable goods like automobiles and electronics [2] - Despite the slowdown, unemployment claims remain stable, indicating that the service sector is less affected, and employment in this sector remains robust [2] - Inflation is expected to rebound temporarily from May to August, with the Federal Reserve likely to maintain interest rates until September, when a potential rate cut may occur [2] Industry Commentary - The Chinese pharmaceutical sector is experiencing a strong trend in innovative drug exports, with several significant business development transactions occurring despite recent tariff tensions [5][6] - The MSCI China Healthcare Index has risen by 14.9% since early 2025, although it has underperformed compared to the broader MSCI China Index [5] - The US innovative drug prices are unlikely to decrease in the short term due to recent executive orders, but long-term pressures on healthcare spending are anticipated [7] Company Initiation - The report covers Angelalign Technology (6699 HK), a leading provider of invisible orthodontic solutions in China, which has maintained a market share of 42% in the domestic market [9][10] - The company is expected to achieve a revenue compound annual growth rate (CAGR) of 23.8% from 2019 to 2024, with a projected CAGR of 18.0% from 2024 to 2027 [9] - Angelalign is expanding internationally, with a goal to cover over 50 countries and achieve significant revenue growth from overseas markets, which is expected to account for 30% of total revenue by 2024 [11][12]